CHESTGuidelines & Topic CollectionsAdvancements in Navigating Immune Suppression, ABPA, Inhaled Antibiotics, and Microbiology in Bronchiectasis

Advancements in Navigating Immune Suppression, ABPA, Inhaled Antibiotics, and Microbiology in Bronchiectasis

Recorded: July 14, 2025

Screening and managing bronchiectasis in obstructive airways diseases can be complex. In this webinar, speakers provide insights on managing immune suppression and chronic infection in rheumatological diseases. They also discuss the impact of biologic therapy in allergic bronchopulmonary aspergillosis (ABPA) and managing diverse etiologies of infections in patients with bronchiectasis. Tune in to this webinar from the CHEST Airways Disorders Network’s Bronchiectasis Section to learn more about screening, risk stratification, monitoring progression, and identifying pharmacotherapy options.

Watch more from this Section: Bronchiectasis Breakthroughs: Many Pathways, One Mission »

Advertisement

Panelist

Nauman Chaudary, MBBS, FCCP

Professor
Internal Medicine
Virginia Commonwealth University Health System
Richmond, VA

Panelist

Sunjay R. Devarajan, MD, FCCP

Assistant Professor, Pulmonary/Critical Care
Associate Director, Adult Cystic Fibrosis Program
Co-Director, Nontuberculous Mycobacterial Diseases Program
Baylor College of Medicine
Houston, TX

Panelist

Malvika Kaul, MD

Assistant Professor, Clinical Medicine
Division of Pulmonary, Critical Care, Sleep, and Allergy
University of Illinois at Chicago
Chicago, IL

Panelist

Chetana Pendkar, MBBS, FCCP

Pulmonologist and Critical Care Specialist
Bellin Health
Green Bay, WI

Advertisement